Metraipolis › archive › dc_221c10ff541e
Mechanistic insight into the oxidative degradation of monoclonal antibodies: relevance to developability and the design of stable pharmaceutical formulations — Europe PMC PMID:42132105
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42132105
- DOI
- 10.1042/bst20250134
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T19:55:11.616Z
- SHA-256 of the archived text
41be29c800b0340905733c3cc392a8391b03d2434851213b25d60fe8a4b76088- Stable URL of this page
https://metraipolis.com/documento/dc_221c10ff541e
How to cite
Mechanistic insight into the oxidative degradation of monoclonal antibodies: relevance to developability and the design of stable pharmaceutical formulations — Europe PMC PMID:42132105 — Europe PMC (en), https://europepmc.org/article/MED/42132105 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_221c10ff541e (Metraipolis archive dc_221c10ff541e, sha256 41be29c800b0340905733c3cc392a8391b03d2434851213b25d60fe8a4b76088)
BibTeX
@misc{dc221c10ff541e,
title = {Mechanistic insight into the oxidative degradation of monoclonal antibodies: relevance to developability and the design of stable pharmaceutical formulations — Europe PMC PMID:42132105},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42132105},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_221c10ff541e; sha256 41be29c800b0340905733c3cc392a8391b03d2434851213b25d60fe8a4b76088},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42132105. Agents can read the archived copy with the MCP tool read_document.